These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30824181)

  • 1. Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
    Wewers TM; Mayer AB; Pfleiderer A; Beul K; Schmidt R; Heitplatz B; Van Marck V; Nolte I; Pavenstädt H; Reuter S; Brand M; Di Marco GS
    Kidney Int; 2019 May; 95(5):1091-1102. PubMed ID: 30824181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased soluble Flt-1 correlates with delayed graft function and early loss of peritubular capillaries in the kidney graft.
    Chapal M; Néel M; Le Borgne F; Meffray E; Carceles O; Hourmant M; Giral M; Foucher Y; Moreau A; Fakhouri F
    Transplantation; 2013 Oct; 96(8):739-44. PubMed ID: 23912175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.
    Yang B; Dieudé M; Hamelin K; Hénault-Rondeau M; Patey N; Turgeon J; Lan S; Pomerleau L; Quesnel M; Peng J; Tremblay J; Shi Y; Chan JS; Hébert MJ; Cardinal H
    Am J Transplant; 2016 Dec; 16(12):3416-3429. PubMed ID: 27172087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Study of Relationship between Serum Levels of Soluble fms-like Tyrosine Kinase-1 and Soluble Fibrinogen-like Protein 2 with Delayed Graft Function after Kidney Transplantation.
    Akbari H; Hooshyar Z; Shabanitabar S; Salmani A; Nikoueinejad H; Einollahi B
    Iran J Allergy Asthma Immunol; 2019 Aug; 18(4):412-418. PubMed ID: 31522449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determinants, biomarkers, and consequences of microvascular injury in kidney transplant recipients.
    Doreille A; Dieudé M; Cardinal H
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F9-F19. PubMed ID: 30379097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemia reperfusion injury in kidney transplantation: A case report.
    Philipponnet C; Aniort J; Garrouste C; Kemeny JL; Heng AE
    Medicine (Baltimore); 2018 Dec; 97(52):e13650. PubMed ID: 30593134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Soluble Fms-like Tyrosine Kinase in Renal Diseases Other than Preeclampsia.
    Wewers TM; Schulz A; Nolte I; Pavenstädt H; Brand M; Di Marco GS
    J Am Soc Nephrol; 2021 Aug; 32(8):1853-1863. PubMed ID: 34155060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis.
    Onoue K; Uemura S; Takeda Y; Somekawa S; Iwama H; Imagawa K; Nishida T; Morikawa Y; Takemoto Y; Asai O; Soeda T; Okayama S; Ishigami K; Nakatani K; Kawata H; Horii M; Nakajima T; Akai Y; Iwano M; Saito Y
    Circulation; 2009 Dec; 120(24):2470-7. PubMed ID: 19948974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary IL-8 is a marker of early and long-term graft function after renal transplantation.
    Kwiatkowska E; Domański L; Bober J; Safranow K; Szymańska-Pasternak J; Sulecka A; Pawlik A; Ciechanowski K; Kwiatkowski S
    Ren Fail; 2017 Nov; 39(1):484-490. PubMed ID: 28494217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel therapy to attenuate acute kidney injury and ischemic allograft damage after allogenic kidney transplantation in mice.
    Gueler F; Shushakova N; Mengel M; Hueper K; Chen R; Liu X; Park JK; Haller H; Wensvoort G; Rong S
    PLoS One; 2015; 10(1):e0115709. PubMed ID: 25617900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Kidney Injury, Microvascular Rarefaction, and Estimated Glomerular Filtration Rate in Kidney Transplant Recipients.
    Doreille A; Azzi F; Larivière-Beaudoin S; Karakeussian-Rimbaud A; Trudel D; Hébert MJ; Dieudé M; Patey N; Cardinal H
    Clin J Am Soc Nephrol; 2021 Mar; 16(3):415-426. PubMed ID: 33648972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function.
    Castellano G; Intini A; Stasi A; Divella C; Gigante M; Pontrelli P; Franzin R; Accetturo M; Zito A; Fiorentino M; Montinaro V; Lucarelli G; Ditonno P; Battaglia M; Crovace A; Staffieri F; Oortwijn B; van Amersfoort E; Pertosa G; Grandaliano G; Gesualdo L
    Am J Transplant; 2016 Jan; 16(1):325-33. PubMed ID: 26280899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis.
    Greite R; Thorenz A; Chen R; Jang MS; Rong S; Brownstein MJ; Tewes S; Wang L; Baniassad B; Kirsch T; Bräsen JH; Lichtinghagen R; Meier M; Haller H; Hueper K; Gueler F
    Am J Physiol Renal Physiol; 2018 May; 314(5):F881-F892. PubMed ID: 29357437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure.
    Hammadah M; Georgiopoulou VV; Kalogeropoulos AP; Weber M; Wang X; Samara MA; Wu Y; Butler J; Tang WH
    Circ Heart Fail; 2016 Jan; 9(1):e002115. PubMed ID: 26699385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective function of miR-378 in the ischemia-reperfusion injury during renal transplantation and subsequent interstitial fibrosis of the renal allograft.
    Xiong L; Ding S; Yang T
    Int Urol Nephrol; 2020 Sep; 52(9):1791-1800. PubMed ID: 32661619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury.
    Yang B; Lan S; Dieudé M; Sabo-Vatasescu JP; Karakeussian-Rimbaud A; Turgeon J; Qi S; Gunaratnam L; Patey N; Hébert MJ
    J Am Soc Nephrol; 2018 Jul; 29(7):1900-1916. PubMed ID: 29925521
    [No Abstract]   [Full Text] [Related]  

  • 17. Stem cell factor, interleukin-16, and interleukin-2 receptor alpha are predictive biomarkers for delayed and slow graft function.
    Alachkar N; Ugarte R; Huang E; Womer KL; Montgomery R; Kraus E; Rabb H
    Transplant Proc; 2010 Nov; 42(9):3399-405. PubMed ID: 21094786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation.
    Morozumi K; Takeda A; Otsuka Y; Horike K; Gotoh N; Narumi S; Watarai Y; Kobayashi T
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():4-8. PubMed ID: 26971899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble fms-Like Tyrosine Kinase 1 as a Link Between Angiogenesis and Endothelial Dysfunction in Pediatric Patients With β-Thalassemia Intermedia.
    Tantawy AAG; Adly AAM; Ismail EAR; Youssef OI; Ali ME
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):943-950. PubMed ID: 28301910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.